Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model

Neuroscience

Volumn 242, Issue , 2013, Pages 1-10

  Inui, T ^a,b   Alessandri, B ^a   Heimann, A ^a   Nishimura, F ^b   Frauenknecht, K ^a   Sommer, C ^a   Kempski, O ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Ceftriaxone; Cortical spreading depression; Glutamate transporter 1; Penumbra; Venous ischemia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; CEFTRIAXONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; AUTORADIOGRAPHY; BLOOD GAS ANALYSIS; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MALE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN ISCHEMIA; CEFTRIAXONE; CEREBRAL INFARCTION; CORTICAL SPREADING DEPRESSION; DRUG INTERACTIONS; EXCITATORY AMINO ACID TRANSPORTER 2; KAINIC ACID; MALE; NEUROPROTECTIVE AGENTS; POTASSIUM CHLORIDE; RATS; RECEPTORS, AMPA; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84876718117     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.03.018     Document Type: Article

References (48)

1. Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron 1993, 11:401-407.
2. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
3. Chu K., Lee S.T., Sinn D.I., Ko S.Y., Kim E.H., Kim J.M., Kim S.J., Park D.K., Jung K.H., Song E.C., Lee S.K., Kim M., Roh J.K. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 2007, 38:177-182.
4. Diederich K., Frauenknecht K., Minnerup J., Schneider B.K., Schmidt A., Altach E., Eggert V., Sommer C.J., Schabitz W.R. Citicoline enhances neuroregenerative processes after experimental stroke in rats. Stroke 2012, 43:1931-1940.
5. Diederich K., Quennet V., Bauer H., Muller H.D., Wersching H., Schabitz W.R., Minnerup J., Sommer C. Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy. Stroke 2012, 43:185-192.
6. Feustel P.J., Jin Y., Kimelberg H.K. Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke 2004, 35:1164-1168.
7. Gong S.J., Chen L.Y., Zhang M., Gong J.X., Ma Y.X., Zhang J.M., Wang Y.J., Hu Y.Y., Sun X.C., Li W.B., Zhang Y. Intermittent hypobaric hypoxia preconditioning induced brain ischemic tolerance by up-regulating glial glutamate transporter-1 in rats. Neurochem Res 2012, 37:527-537.
8. Granero L., Santiago M., Cano J., Machado A., Peris J.E. Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrob Agents Chemother 1995, 39:2728-2731.
9. Guyot L.L., Diaz F.G., O'Regan M.H., McLeod S., Park H., Phillis J.W. Real-time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model. Neurosci Lett 2001, 299:37-40.
10. Huh K.H., Wenthold R.J. Turnover analysis of glutamate receptors identifies a rapidly degraded pool of the N-methyl-d-aspartate receptor subunit, NR1, in cultured cerebellar granule cells. J Biol Chem 1999, 274:151-157.
11. Kempski O., Seiwert T., Otsuka H., Heimann A., Nakase H. Modelling of the ischemic penumbra. Acta Neurochir Suppl 1999, 73:41-44.
12. Kimura R., Nakase H., Tamaki R., Sakaki T. Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. Stroke 2005, 36:1259-1263.
13. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 1995, 15:1835-1853.
14. Lipski J., Wan C.K., Bai J.Z., Pi R., Li D., Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 2007, 146:617-629.
15. Maragakis N.J., Dietrich J., Wong V., Xue H., Mayer-Proschel M., Rao M.S., Rothstein J.D. Glutamate transporter expression and function in human glial progenitors. Glia 2004, 45:133-143.
16. Miller B.R., Dorner J.L., Shou M., Sari Y., Barton S.J., Sengelaub D.R., Kennedy R.T., Rebec G.V. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 2008, 153:329-337.
17. Mimura K., Tomimatsu T., Minato K., Jugder O., Kinugasa-Taniguchi Y., Kanagawa T., Nozaki M., Yanagihara I., Kimura T. Ceftriaxone preconditioning confers neuroprotection in neonatal rats through glutamate transporter 1 upregulation. Reprod Sci 2012, 18:1193-1201.
18. 3H]glutamate-binding sites in rat brain. J Neurosci 1985, 5:2909-2919.
19. Nakagawa I., Alessandri B., Heimann A., Kempski O. MitoKATP-channel opener protects against neuronal death in rat venous ischemia. Neurosurgery 2005, 57:334-340. discussion 334-340.
20. Nakase H., Kakizaki T., Miyamoto K., Hiramatsu K., Sakaki T. Use of local cerebral blood flow monitoring to predict brain damage after disturbance to the venous circulation: cortical vein occlusion model by photochemical dye. Neurosurgery 1995, 37:280-285. discussion 285-286.
21. Nakase H., Heimann A., Kempski O. Local cerebral blood flow in a rat cortical vein occlusion model. J Cereb Blood Flow Metab 1996, 16:720-728.
22. Nakase H., Kempski O.S., Heimann A., Takeshima T., Tintera J. Microcirculation after cerebral venous occlusions as assessed by laser Doppler scanning. J Neurosurg 1997, 87:307-314.
23. Nakase H., Nagata K., Ohtsuka H., Sakaki T., Kempski O. An experimental model of intraoperative venous injury in the rat. Skull Base Surg 1997, 7:123-128.
24. Nakase H., Nagata K., Otsuka H., Sakaki T., Kempski O. Local cerebral blood flow autoregulation following "asymptomatic" cerebral venous occlusion in the rat. J Neurosurg 1998, 89:118-124.
25. Nederkoorn P.J., Westendorp W.F., Hooijenga I.J., de Haan R.J., Dippel D.W., Vermeij F.H., Dijkgraaf M.G., Prins J.M., Spanjaard L., van de Beek D. Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke 2011, 6:159-163.
26. Otsuka H., Ueda K., Heimann A., Kempski O. Effects of cortical spreading depression on cortical blood flow, impedance, DC potential, and infarct size in a rat venous infarct model. Exp Neurol 2000, 162:201-214.
27. Palacios J.M., Wamsley J.K., Kuhar M.J. High affinity GABA receptors-autoradiographic localization. Brain Res 1981, 222:285-307.
28. Patel I.H., Chen S., Parsonnet M., Hackman M.R., Brooks M.A., Konikoff J., Kaplan S.A. Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother 1981, 20:634-641.
29. Phillis J.W., Ren J., O'Regan M.H. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with d l-threo-beta-benzyloxyaspartate. Brain Res 2000, 868:105-112.
30. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain l-glutamate transporter. Nature 1992, 360:464-467.
31. Rao V.L., Bowen K.K., Dempsey R.J. Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem Res 2001, 26:497-502.
32. Rao V.L., Dogan A., Todd K.G., Bowen K.K., Kim B.T., Rothstein J.D., Dempsey R.J. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J Neurosci 2001, 21:1876-1883.
33. Romera C., Hurtado O., Botella S.H., Lizasoain I., Cardenas A., Fernandez-Tome P., Leza J.C., Lorenzo P., Moro M.A. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J Neurosci 2004, 24:1350-1357.
34. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403:316-321.
35. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13:713-725.
36. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
37. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
38. Sari Y., Smith K.D., Ali P.K., Rebec G.V. Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci 2009, 29:9239-9243.
39. Seki Y., Feustel P.J., Keller R.W., Tranmer B.I., Kimelberg H.K. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 1999, 30:433-440.
40. Standley S., Tocco G., Tourigny M.F., Massicotte G., Thompson R.F., Baudry M. Developmental changes in alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor properties and expression in the rat hippocampal formation. Neuroscience 1995, 67:881-892.
41. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990, 348:443-446.
42. Takeshima Y., Nakamura M., Miyake H., Tamaki R., Inui T., Horiuchi K., Wajima D., Nakase H. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model. Neurosurgery 2011, 68:1334-1341.
43. Uranishi R., Nakase H., Sakaki T., Kempski O.S. Evaluation of absolute cerebral blood flow by laser-Doppler scanning - comparison with hydrogen clearance. J Vasc Res 1999, 36:100-105.
44. Van Harreveld A. Two mechanisms for spreading depression in the chicken retina. J Neurobiol 1978, 9:419-431.
45. Verma R., Mishra V., Sasmal D., Raghubir R. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur J Pharmacol 2010, 638:65-71.
46. Wajima D., Nakamura M., Horiuchi K., Takeshima Y., Nishimura F., Nakase H. Cilostazol minimizes venous ischemic injury in diabetic and normal rats. J Cereb Blood Flow Metab 2011, 31:2030-2040.
47. Zhang M., Li W.B., Geng J.X., Li Q.J., Sun X.C., Xian X.H., Qi J., Li S.Q. The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J Cereb Blood Flow Metab 2007, 27:1352-1368.
48. Zilles K., Wu J., Crusio W.E., Schwegler H. Water maze and radial maze learning and the density of binding sites of glutamate, GABA, and serotonin receptors in the hippocampus of inbred mouse strains. Hippocampus 2000, 10:213-225.